Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Acasti Pharma Inc
ACST
Healthcare
Acasti Pharma Inc. is a Canada-based late-stage biopharma company with drug candidates addressing rare and orphan diseases. The Company is targeting three underserved orphan diseases: GTX-104, an intravenous infusion targeting subarachnoid hemorrhage (SAH), a rare and life-threatening medical emergency, in which bleeding occurs over the surface of the brain in the subarachnoid space between the...
brain and skull; GTX-102, an oral mucosal spray targeting ataxia-telangiectasia (A-T), a progressive, neurodegenerative genetic disease that primarily impacts children causing severe disability; and GTX-101, a topical spray, targeting postherpetic neuralgia, a persistent and often debilitating neuropathic pain caused by nerve damage from the varicella zoster virus (shingles). The Company’s clinical assets have each been granted Orphan Drug Designation by the FDA, which provides seven years of marketing exclusivity post-launch in the United States, and additional intellectual property protection.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ACST)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(80)
•••
bingostar
X
View Profile
View Bullboard History
Post by
bingostar
on Dec 22, 2022 6:08pm
the perfect situation
With a market cap trading under the cash in the cie and 3 products in clinic phase announcing news in the coming weeks you cannot dream of a better scenario . On top of it the CEO Pierre
...more
(51)
•••
Canadian_101
X
View Profile
View Bullboard History
Comment by
Canadian_101
on Nov 21, 2022 3:26pm
RE:GTX-104 positive results
No One is paying attention to them, look at the decline in share price, its hard to believe they are still around, glad I dumped when they delayed their results for capri, I would not invest a dime in
...more
(80)
•••
bingostar
X
View Profile
View Bullboard History
Post by
bingostar
on May 18, 2022 1:19pm
GTX-104 positive results
As annouced today: Acasti Pharma Announces Positive Results for Pharmacokinetic Bridging Study, With Intravenous GTX-104 Meeting All Endpoints :: Acasti Pharma Inc. (ACST) They have 3 products
...more
(1862)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Apr 25, 2022 8:45am
Acasti Pharma to Present
LAVAL, Qubec, April 25, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced that Prashant Kohli, Vice President of Commercial
...more
(15)
•••
alanmar1
X
View Profile
View Bullboard History
Post by
alanmar1
on Apr 03, 2022 4:21pm
acasti
Credability at work.This stock has not yet met any significant forcast.Carepre was badly promoted and the real reason it failed has never been fully ex[plained.Later the promise of licensing Care pre
...more
(1)
•••
flush777
X
View Profile
View Bullboard History
Comment by
flush777
on Jan 05, 2022 1:56pm
RE:Over 200K on the bid, which is 1% of outstanding shares
Now 131,900 at the bid of $1.86 ... I think this or these buyers are very hungry buyers ... Let the wolves feast and pick up all the low hanging fruit awaiting conference news... hopefully very very
...more
(1)
•••
flush777
X
View Profile
View Bullboard History
Comment by
flush777
on Jan 05, 2022 1:51pm
RE:Oppenheimer report on Acasti, outperform, target US $6
ok, the issuance of the report triggered a rush to a high of $2.30 on Dec 22, 2021. I guess that the whole world knows of the report ... except that it takes time for analysis and thoughts and yes, I
...more
(1)
•••
flush777
X
View Profile
View Bullboard History
Post by
flush777
on Jan 05, 2022 12:45pm
Oppenheimer report on Acasti, outperform, target US $6
Report dated Dec 21, 2021 ... Hum, graph looks great for any potential investor ...
(1)
•••
flush777
X
View Profile
View Bullboard History
Post by
flush777
on Jan 05, 2022 12:26pm
Over 200K on the bid, which is 1% of outstanding shares
being whittled away at $1.85. Really good sign for the future!
(52)
•••
Francine01
X
View Profile
View Bullboard History
Post by
Francine01
on Dec 06, 2021 11:12am
SP Value
SP value is below cash in bank account. I didn't knew that this could be possible for a plublic company. Good job Jan!
(51)
•••
Canadian_101
X
View Profile
View Bullboard History
Comment by
Canadian_101
on Nov 06, 2021 10:12am
RE:For the record
What a SH_IT Show this has been, thank god I dumped all my shares and moved on before they announced the final results, my spider sense told me something was majorly wrong when they delayed the
...more
(4)
•••
19LDS84
X
View Profile
View Bullboard History
Comment by
19LDS84
on Oct 06, 2021 8:45pm
RE:Awarded Composition-of-Matter Patents for GTX-101
The best news here is the parents are good until 2036, which gives Jan plenty of time to f#$k this up again.... glta
(1862)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Oct 06, 2021 8:34am
Awarded Composition-of-Matter Patents for GTX-101
LAVAL, Qubec, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announces that the European Patent Office, Chinese Patent Office
...more
(15)
•••
alanmar1
X
View Profile
View Bullboard History
Post by
alanmar1
on Oct 02, 2021 11:01am
Acasti pharma
This is directed to Francine ,a dedicated ACST follower and righty so based on data available. Francine, if you still own ACST stock I recomend you move some of your investment into WML. You
...more
(561)
•••
Justhalffull
X
View Profile
View Bullboard History
Post by
Justhalffull
on Sep 05, 2021 4:27pm
For the record
If you had invested $10,000 on Feb 7 2012, you would now have 245.87. If you need any more evidence about this outfit, you should not be investing in stocks.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Significant New Silver Discoveries in the Famous Keno Hill District in the Yukon
An Opportunity to Join Pulsar Helium on the Ground in Minnesota for a Historic Reservoir Flow Test